Kailera Therapeutics Statistics
Total Valuation
KLRA has a market cap or net worth of $1.68 billion. The enterprise value is $656.49 million.
| Market Cap | 1.68B |
| Enterprise Value | 656.49M |
Important Dates
The last earnings date was Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KLRA has 129.85 million shares outstanding.
| Current Share Class | 129.85M |
| Shares Outstanding | 129.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +26.83% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 44.80% |
| Float | 58.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.63 |
| P/TBV Ratio | 1.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.84, with a Debt / Equity ratio of 0.01.
| Current Ratio | 21.84 |
| Quick Ratio | 21.55 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -36.49% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.40M |
| Employee Count | 145 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 12.78 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 53.17 |
| Average Volume (20 Days) | 1,019,398 |
Short Selling Information
The latest short interest is 8.32 million, so 6.40% of the outstanding shares have been sold short.
| Short Interest | 8.32M |
| Short Previous Month | 8.68M |
| Short % of Shares Out | 6.40% |
| Short % of Float | 14.17% |
| Short Ratio (days to cover) | 5.58 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -379.49M |
| Pretax Income | -348.24M |
| Net Income | -348.24M |
| EBITDA | -379.07M |
| EBIT | -379.49M |
| Earnings Per Share (EPS) | -$2.69 |
Balance Sheet
The company has $901.45 million in cash and $9.97 million in debt, with a net cash position of $1.03 billion or $7.91 per share.
| Cash & Cash Equivalents | 901.45M |
| Total Debt | 9.97M |
| Net Cash | 1.03B |
| Net Cash Per Share | $7.91 |
| Equity (Book Value) | 1.03B |
| Book Value Per Share | 7.95 |
| Working Capital | 877.64M |
Cash Flow
In the last 12 months, operating cash flow was -$325.59 million and capital expenditures -$1.65 million, giving a free cash flow of -$327.23 million.
| Operating Cash Flow | -325.59M |
| Capital Expenditures | -1.65M |
| Depreciation & Amortization | 425,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -327.23M |
| FCF Per Share | -$2.52 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KLRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -20.71% |
| FCF Yield | -19.43% |
Analyst Forecast
The average price target for KLRA is $42.75, which is 229.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $42.75 |
| Price Target Difference | 229.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |